CiceroDiagnostics, Inc.

CiceroDiagnostics, Inc. is a leading diagnostics company dedicated to improving patient outcomes in fertility and reproductive health. Based in Henderson, Nevada, we specialize in providing innovative clinical assays for the early detection of endometriosis, a condition affecting over 176 million women worldwide. Our ReceptivaDx test represents a new generation of testing, offering a reliable and less invasive method to identify BCL6, a key marker associated with endometriosis and its impact on fertility. By expediting patient referrals to endometriosis specialists and facilitating targeted treatment plans, Cicero Diagnostics empowers healthcare providers to significantly improve the chances of successful pregnancies for their patients. Supported by extensive clinical data and ongoing research collaborations with leading academic institutions, we are committed to advancing the understanding and treatment of endometriosis and related reproductive challenges.